Optomed: Decreased full-year outlook - Redeye

Redeye comments on Optomed’s profit warning, where the company expects its revenues to decrease compared to 2023. We do not place too much weight on the updated outlook; however, we make some changes to our revenue estimates, rendering an updated fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/1040959/optomed-decreased-full-year-outlook?utm_source=finwire&utm_medium=RSS